Johnson & Johnson

The federal government has reached a deal worth up to $2.1 billion with drugmakers Sanofi and GlaxoSmithKline as part of Operation Warp Speed, the Trump administration's push to have a coronavirus vaccine widely available by early 2021.

The money will go toward clinical trials, scaling up manufacturing and purchasing 100 million doses of the vaccine.

The federal government has reached a $1.95 billion deal with Pfizer to acquire 100 million doses of its vaccine candidate against the coronavirus if the Food and Drug Administration OKs it. The vaccine would be free to Americans, according to the deal, though health care providers could charge to administer it.

Johnson & Johnson has announced it will discontinue two lines of skin-lightening products popular in Asia, making it one of the latest major companies to change business tactics seen as racist amid the global debate over racial inequality.

Johnson & Johnson will stop selling talcum-based baby powder in the United States and Canada after being ordered to pay out billions of dollars related to lost legal battles over claims the product causes cancer.

The company made the announcement Tuesday. It denied allegations that the powder is responsible for health problems.

Johnson & Johnson via Facebook

Kentucky will receive more than a half-million dollars in a settlement with a Johnson & Johnson subsidiary over nonprescription drugs.

Kentucky Office of the Attorney General via YouTube

Researchers at the University of Louisville will monitor Kentucky's quest to rid itself of a backlog of untested rape kits and offer recommendations on how to avoid such log-jams in the future.

Kentucky Medicaid Settles with Johnson & Johnson for $7 Million

Jun 13, 2012

Kentucky Attorney General Jack Conway recovered $7 million on behalf of Kentucky’s Medicaid program following a settlement with 47 companies in the Johnson & Johnson family.